BRANDL TALOS advised Graph Therapeutics on the deal, Sqareone was advised by Schönherr, while NAVEC was represented by Herbst Kinsky and the Atomico Angel Program was…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
